Position history for Qube Research & Technologies Ltd's holdings in Terns Pharmaceuticals, Inc.
Qube Research & Technologies Ltd holds 7,664 shares of TERN (Terns Pharmaceuticals, Inc.), worth $309,626 as of 2025-Q4. The position was decreased (-90.0% shares). TERN represents 0.0% of Qube Research & Technologies Ltd's portfolio.
Current Value
$309,626
Current Shares
7,664
Total Value Change
-$3.5M
Total Shares Change
-449,275
Other major holders of TERN: BlackRock, Inc., MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Avoro Capital Advisors LLC
Decreased |
| 7,664 |
-90.0% |
| $309,626 |
| 0.0% |
| $40.59 |
0 |
| 2025-Q3 | Decreased | 76,782 | -77.2% | $576,633 | 0.0% | $7.79 | 0 |
| 2025-Q2 | Decreased | 336,665 | -51.6% | $1.3M | 0.0% | $3.83 | 0 |
| 2025-Q1 | Increased | 695,159 | +121.1% | $1.9M | 0.0% | $2.92 | 42 |
| 2024-Q4 | Decreased | 314,389 | -31.2% | $1.7M | 0.0% | $5.53 | 0 |
| 2024-Q3 | New | 456,939 | - | $3.8M | 0.0% | $8.55 | 37 |